Core Viewpoint - The article highlights the performance of private equity funds in the range of 5-10 billion, indicating a strong average return of 24.25% year-to-date, with stock strategy products significantly outperforming the market [1][2]. Group 1: Performance Overview - There are 570 products under private equity funds with performance data, totaling approximately 951.82 billion yuan, with an average return of 24.25% this year [1][2]. - Stock strategy products, totaling 470, have an average return of 26.58%, outperforming the market significantly [1][2]. - Futures and derivatives strategy products have lagged behind, with only 25 products showing an average return of 6.04% this year [1][2]. Group 2: Strategy Breakdown - The performance of various strategies is as follows: - Stock Strategy: 470 products, 7,909,036.93 million yuan, 8-month return of 6.23%, year-to-date return of 26.58% [2]. - Multi-Asset Strategy: 79 products, 1,083,120.75 million yuan, 8-month return of 5.79%, year-to-date return of 17.97% [2]. - Futures and Derivatives Strategy: 25 products, 241,368.31 million yuan, 8-month return of 1.24%, year-to-date return of 6.04% [2]. - Bond Strategy: 17 products, 228,625.42 million yuan, 8-month return of 1.32%, year-to-date return of 5.66% [2]. - Combination Fund: 3 products, 56,001.36 million yuan, 8-month return of 9.33%, year-to-date return of 31.87% [2]. Group 3: Quantitative Strategy Performance - There are 76 quantitative long products with an average return of 36.30% year-to-date, outperforming the average [3][4]. - The top three quantitative long products for the year are from Pansong Asset, Beiyang Quantitative, and Zhengying Asset [4]. Group 4: Subjective Long Strategy Performance - 82 subjective long products have an average return of 30.86% year-to-date, benefiting from a strong equity market [7][8]. - The top three subjective long products are from Yuanxin Investment, Tongben Investment, and Kangmand Capital [8]. Group 5: Market Neutral Strategy Performance - 37 market-neutral products have an average return of 6.53% year-to-date, with the top three products from Pansong Investment, Liangkui Private Equity, and Pansong Asset [11][12]. Group 6: Multi-Asset Strategy Performance - 79 multi-asset strategy products have an average return of 14.51% year-to-date, with the top three products from Guoyuan Xinda, Luoshu Investment, and Chanlong Asset [13][14]. Group 7: Futures and Derivatives Strategy Performance - 52 futures and derivatives strategy products have an average return of 8.92% year-to-date, with the top three products from Hongxi Fund, Luoshu Investment, and Jiahong Fund [15][16].

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 8月份，A股三大股指继续强势上涨，同时，成交额来到了历史高位水平，市场交投活跃。8月份，上证指数的涨幅为7.97%，深证成指的涨幅为 15.32%，创业板指的涨幅为24.13%。 在这样的市场背景下， 有 3321只私募产品（在私募排排网有业绩展示且成立满1年）在今年8月份净值曾创下历史新高，占成立满1年的私募产 品的比例约为71.19%。 按产品类型来看，量化产品占 1303只，非量化产品占2018只 。 按照产品策略（一级策略）来看，股票策略产品最多（主要是主观多头和量化 多头），有 2135只，占比约64%； 其次是多资产策略产品占471只，期货及衍生品策略产品占305只，债券策略产品占302只，组合基金产品占 108只。 按公司规模来看，来自5亿以下规模私募的产品最多，有1347只，占比超4成；来自百亿私募的产品有456只。 为了给读者提供一些参考， 笔者在创新高私募产品中按照产品策略分别梳理出了 "股票策略-主观多头、股票策略-量化多头、期货及衍生品策 略、多资产策略、债券策略"近一年收益居前20强的私募产品（公司规模在5亿以上）； 此 ...

Core Insights - The Hangzhou futures circle has evolved into an ecosystem characterized by "industrial capital + private equity funds + futures asset management" since its rise in 2015, with Yong'an Futures being a leading player in the national "first tier" [1] - The primary reason for the recent losses in the Hangzhou futures circle is attributed to a lag in responding to policy rhythms, emotional capital, and quantitative capital behaviors, despite its traditional advantage in obtaining frontline intelligence [1] - As of August 15, 2025, there are 690 futures and derivatives strategy products with performance displays, with 79 products from Hangzhou, ranking third in quantity [2] Performance Overview - Hangzhou's futures and derivatives strategy products have achieved an average return of 11.69% this year, ranking second, with a near one-month average return of 2.69% [2] - Among the 79 products in Hangzhou, both quantitative CTA and subjective CTA products number around 30 each, with other derivative strategies and subjective CTA strategies averaging over 16% returns, ranking in the top two [2][3] - The top 10 products in Hangzhou have a performance threshold of ***%, with 62% of subjective CTA products showing positive returns in the last month [3][5] Company Rankings - Eight private equity firms in Hangzhou have at least three qualifying products, with the top three being mixed-type (subjective + quantitative) private equity firms [8] - The top three firms by performance are: 1. Zaiying Private Equity with an average return of approximately ***% over the past year [10] 2. Junfu Investment with an average return of approximately ***% over the past year [11] 3. Qiantang Yongli Asset Management with an average return of approximately ***% over the past year [12] - Junfu Investment and Qiantang Yongli Asset Management are both in the 20-50 billion scale range, indicating significant asset management capabilities [8][12]

Core Viewpoint - The article highlights the strong performance of the stock market and private equity funds in July, with significant increases in various indices and a surge in the number of private equity fund registrations, indicating renewed investor confidence [1]. Group 1: Market Performance - In July, the Shanghai Composite Index rose by 3.74%, surpassing 3600 points, while the Shenzhen Component Index increased by 5.20%, and the ChiNext Index saw an 8.14% rise [1]. - The Nanhua Commodity Index experienced a monthly increase of 3.80%, with industrial products up by 4.86% and black products rising by 8.52% [1]. Group 2: Private Equity Fund Trends - July marked a peak in private equity fund registrations, with the number of registered private equity securities funds reaching a 27-month high, primarily focusing on stock strategies, multi-asset strategies, and futures and derivatives strategies [1]. - As of July 2025, there were 4425 private equity products that met ranking criteria, with stock strategies (2737 products), futures and derivatives strategies (617 products), and multi-asset strategies (602 products) making up nearly 90% of the total [1]. Group 3: Performance of Private Equity Strategies - The average returns for various strategies as of July 2025 are as follows: - Stock strategies: 19.04% (year-to-date), 45.10% (1-year), 45.54% (3-year) - Futures and derivatives strategies: 7.45% (year-to-date), 18.01% (1-year), 38.92% (3-year) - Multi-asset strategies: 11.58% (year-to-date), 29.40% (1-year), 41.98% (3-year) - Overall average return for all products: 15.23% (year-to-date), 36.26% (1-year), 42.96% (3-year) [2]. Group 4: Top Private Equity Firms - The top three private equity firms in stock strategies based on year-to-date returns are: - Tongben Investment - Fusheng Asset - Wenbo Investment [3]. - For multi-asset strategies, the leading firms are: - Guoyuan Xinda - Junchen Asset - Yiying Asset [7]. - In the futures and derivatives strategies category, the top firms are: - Shenzhen Liangdao Investment - Hongxi Fund - Junchen Asset [11].

Group 1 - The core viewpoint of the articles highlights the outstanding performance of private equity funds in the A-share market, with an average return of 11.94% for 11,880 private securities products as of July, 86.97% of which achieved positive returns [1] - Stock strategies have shown particularly strong performance, with 7,760 stock strategy products averaging a return of 14.5%, leading among five major strategies, and 88.2% of these products achieving positive returns [1][2] - Top private equity firms have outperformed the industry average, with 55 billion-level private equity firms averaging a return of 16.6%, and 98.18% of them achieving positive returns [1] Group 2 - Multi-asset strategies follow closely behind stock strategies, with 1,364 multi-asset strategy products averaging a return of 9.59%, and 86.66% of these products achieving positive returns [2] - Combination funds have shown stable performance, with 405 combination funds averaging a return of 8.57%, and 92.10% of these products achieving positive returns [2] - In the bond strategy sector, 1,076 bond strategy products have averaged a return of 5.16%, with 91.54% achieving positive returns [3] Group 3 - The outlook for the market is optimistic, supported by reduced global trade uncertainties and the effectiveness of China's economic structural adjustments, with a focus on sectors like technology, innovative pharmaceuticals, and non-bank financials [3] - The company maintains a high position in its portfolio, particularly in sectors such as overseas AI, domestic computing power, and new consumption [3]

Group 1 - The private securities product registration market is experiencing unprecedented activity, with 1,298 products registered in July, a month-on-month increase of 18%, marking the highest level in nearly 27 months. This reflects a significant recovery in market confidence and a sustained demand for private product allocation [1] - The total number of registered products for the year has reached 6,759, representing a year-on-year increase of over 60%, indicating a clear recovery trend in the private issuance market [1] Group 2 - Quantitative private products have been particularly prominent in this registration wave, with 620 quantitative products registered in July, accounting for 47.77% of the total registered products for the month, and a month-on-month growth of nearly 20% [3] - Among the 13 private firms that registered more than 10 products in July, 11 were quantitative firms, with the top ten spots entirely occupied by quantitative institutions. Wide德 Private Fund led with 31 registered products, followed by Mingcong Investment with 26 [3] - Stock quantitative strategies dominate the quantitative product category, with 478 stock strategy quantitative products registered in July, making up 77.10% of the total quantitative products for the month, and a month-on-month increase of 26.79% [3] Group 3 - Stock strategies continue to play a leading role in private product registrations, with 887 stock strategy products registered in July, accounting for 68.34% of the total registered products, and a month-on-month growth of 24.58% [4] - Multi-asset strategies are emerging as a significant force, with 162 products registered in July, representing 12.48% of the total, and a month-on-month increase of 5.88% [4] - Futures and derivatives strategies, bond strategies, and combination fund strategies also show steady growth, with 125, 48, and 46 products registered respectively, indicating a diversification in investment options for investors [4] Group 4 - A total of 676 private institutions completed product registrations in July, including 48 billion-level private funds and 36 funds with 50 to 100 billion in scale, demonstrating active participation across different scales of private institutions [4]

Core Viewpoint - The article discusses the emergence of private equity firms engaging in creative projects, specifically the production of a short drama centered around futures trading, highlighting the challenges and uncertainties in the futures investment landscape [1] Group 1: Short Drama Production - Three private equity firms, Waying Investment, Shanhai Fund, and Shenhan Capital, have produced a short drama titled "Rebirth in the Millennium: My Revenge Path through Futures" [1] - The drama features a billionaire private equity boss who faces significant losses due to market volatility and personal tragedy, ultimately leading to a second chance in the year 2000 [1] Group 2: Performance of Private Equity Products - As of July 25, 2025, there are 603 futures and derivatives strategy products with a total scale of approximately 34.33 billion, with an average return of 8.73% this year [3] - Among these, 339 quantitative CTA products have an average return of 8.31%, while 156 subjective CTA products have an average return of 12.15% [3] Group 3: Top Performing Products - The top three futures and derivatives strategy products for the year are led by Fuhua Zixin's product, with a return of ***% [9] - In the category of private equity firms with a scale below 5 billion, the top three products are from Fuhua Zixin, Jingsheng Investment, and Ruixin Investment [10] Group 4: Recent Performance Trends - Over the past year, 573 products have shown an average return of 20.66%, with quantitative CTA products averaging 19.07% and subjective CTA products averaging 28.76% [9] - The leading products in this category are managed by Xuming Investment and Fuhua Zixin [10] Group 5: Long-Term Performance - Over the past three years, 345 products have an average return of 61.65%, with quantitative CTA products averaging 30.18% and subjective CTA products averaging 74.70% [14] - The top three products in this category are from Fuying Investment, Xuming Investment, and Ruixin Tiansuan [15]

Core Viewpoint - The A-share market's strong rebound has significantly boosted investor confidence, leading to explosive growth in the issuance of new private equity products [1][4]. Group 1: Private Equity Product Issuance - In July, the number of registered private equity securities products reached 1,298, a month-on-month increase of 18%, marking a 27-month high [2][3]. - The total number of registered private equity securities products this year has surged over 60% year-on-year, with quantitative strategies performing particularly well and attracting substantial capital inflows [2][4]. - The cumulative number of registered private equity securities products in the first half of the year reached 5,576, with a total registered scale of 184.13 billion yuan [4]. Group 2: Strategy Distribution - Stock strategies dominated the July registrations, accounting for 887 products, or 68.34% of the total, with a month-on-month growth of 24.58% [5][6]. - Multi-asset strategies and futures/derivatives strategies also showed steady growth, with 162 and 125 products registered in July, respectively [9]. Group 3: Market Dynamics - The strong performance of quantitative strategies has led to a rapid increase in management scale for many quantitative private equity firms, with the top ten registered products all belonging to billion-yuan quantitative institutions [2][6]. - The market's rebound and the outstanding performance of quantitative investments have driven significant capital inflows, reflecting a strong demand for asset allocation [4][7].

Core Insights - The A-share market has shown a structural slow bull trend since the "9.24 market" last year, with stock strategies being the strongest performers in private equity products for the first half of this year and the past year [1] - However, over a longer time frame of three to five years, futures and derivatives strategies have outperformed, with significant gains in commodities like gold and lithium carbonate [1] - As of June 30, 2025, there are 593 futures and derivatives strategy products that meet ranking criteria, with average returns of 39.11% over three years and 97.41% over five years [1][2] Private Equity Strategy Performance - Stock Strategy: 2599 products, average returns of 12.36% (H1), 36.36% (1 year), 35.48% (3 years), and 74.97% (5 years) [2] - Futures and Derivatives Strategy: 593 products, average returns of 5.04% (H1), 18.12% (1 year), 39.43% (3 years), and 98.23% (5 years) [2] - Multi-Asset Strategy: 568 products, average returns of 8.20% (H1), 25.76% (1 year), 37.34% (3 years), and 95.98% (5 years) [2] - Bond Strategy: 325 products, average returns of 5.54% (H1), 13.01% (1 year), 35.14% (3 years), and 82.64% (5 years) [2] - Total: 4206 products, average returns of 10.08% (H1), 30.13% (1 year), 35.81% (3 years), and 80.06% (5 years) [2] Top Performing Private Equity Firms - For firms with over 20 billion in scale, the top three in futures and derivatives strategy returns are Junfu Investment, Junchen Asset, and Loshu Investment [3][5] - Junfu Investment specializes in a variety of asset classes, including commodity strategies and index enhancements [5][6] - For firms with 5-20 billion in scale, the top three are Guanzhi Fund, Zhemeng Investment, and Mingrui (Beijing) Private Equity [9][11] - For firms with 0-5 billion in scale, the top three are Fuying Investment, Qihe New Asset Management, and Mufeng Investment [13][15] Notable Products - Junfu Investment's "Junfu Gold Enhanced No. 1" has shown strong performance with returns above ***% over three years [6][7] - Guanzhi Fund's "Guanzhi Zhaijin Growth No. 1 A Class" also reported impressive returns over three years [12] - Fuying Investment's "Fuying Progress No. 1" leads in returns among small-scale firms, achieving returns above ***% [16]

Core Viewpoint - Since the "9.24 market" last year, the A-share market has shown a structural slow bull trend, with private equity products focusing on stock strategies achieving strong performance in the first half of this year and over the past year. However, over a longer time frame of three to five years, futures and derivatives strategies have shown stronger performance, with significant increases in commodities like gold and lithium carbonate [2][3]. Summary by Category Private Equity Strategy Performance - As of June 30, 2025, there are 593 futures and derivatives strategy products that meet ranking criteria, with average returns of 39.11% over three years and 97.41% over five years, outperforming other strategies [2][3]. - The average returns for various strategies in the first half of the year and over different time frames are as follows: - Stock Strategy: 12.36% (H1), 36.36% (1 year), 35.48% (3 years), 74.97% (5 years) - Futures and Derivatives Strategy: 5.04% (H1), 18.12% (1 year), 39.43% (3 years), 98.23% (5 years) - Multi-Asset Strategy: 8.20% (H1), 25.76% (1 year), 37.34% (3 years), 95.98% (5 years) - Bond Strategy: 5.54% (H1), 13.01% (1 year), 35.14% (3 years), 82.64% (5 years) - Combination Fund: 6.72% (H1), 20.70% (1 year), 15.06% (3 years), 34.10% (5 years) - Overall Average: 10.08% (H1), 30.13% (1 year), 35.81% (3 years), 80.06% (5 years) [3]. Top Performing Private Equity Firms - Among firms with over 20 billion in assets, the top three in futures and derivatives strategy returns over three years are: 1. Junfu Investment 2. Junchen Asset 3. Loshu Investment - The average returns for these firms are not disclosed due to regulatory requirements [4][5]. - Junfu Investment focuses on a diverse range of asset classes, including commodity strategies and various index enhancements, with eight qualifying products showing returns above a certain threshold [6][9]. Mid-Sized Private Equity Firms - For firms with 5-20 billion in assets, the top three in futures and derivatives strategy returns over three years are: 1. Guanzhi Fund 2. Zhemeng Investment 3. Mingrui (Beijing) Private Equity - The average returns for these firms are also not disclosed [10][12]. Small Private Equity Firms - Among firms with 0-5 billion in assets, the top three in futures and derivatives strategy returns over three years are: 1. Fuying Investment 2. Qihe New Asset Management 3. Mufeng Investment - The average returns for these firms exceed a certain threshold, with Fuying Investment's top product showing significant returns [15][16].